Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy & Immunology
Hepatitis C virus therapy alters the efforts of natural killer T cells
November 18th, 2005
Hepatitis C virus therapy alters the efforts of natural killer T cells. According to recent research from Japan, "natural killer T (NKT) cells share features of both classical T cells and NK cells. NKT are heterogenous populations and recognize glycolipids associated with CD1d molecule." "We investigated Th1/Th2 cytokine production as well as frequency and phenotype of circulating NKT cells in 14 healthy subjects and in patients during therapy with type C chronic hepatitis (CH; 14 cases) and hepatocellular carcinoma (HCC; 13 cases)," wrote A. Okumura and colleagues, Aichi Medical University. "Peripheral blood mononuclear cells...
Source: Drug Week (2005-11-18)
|
